Liminal BioSciences (LMNL) Short Interest Ratio & Short Volume

Short interest is the volume of Liminal BioSciences shares that have been sold short but have not yet been covered or closed out. As of September 15th, investors have sold 700 shares of LMNL short. 0.08% of Liminal BioSciences' shares are currently sold short. Learn More on Liminal BioSciences' current short interest.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.08% of Liminal BioSciences' floating shares are currently sold short.

Liminal BioSciences saw a increase in short interest in September. As of September 15th, there was short interest totaling 700 shares, an increase of 133.3% from the previous total of 300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Liminal BioSciences currently has issued a total of 3,100,000 shares. Some of Liminal BioSciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Liminal BioSciences currently has a public float of 902,000 shares.

0.08% of Liminal BioSciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Liminal BioSciences: Qilian International Holding Group Limited (0.07%), DURECT Co. (3.55%), Iterum Therapeutics plc (9.40%), Sol-Gel Technologies Ltd. (0.12%), Forte Biosciences, Inc. (0.09%), Eyenovia, Inc. (11.01%), Acasti Pharma Inc. (0.02%), Lipocine Inc. (2.11%), Vaxxinity, Inc. (9.00%), Unity Biotechnology, Inc. (2.00%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Canadian Natural Resources Limited ($8.05 billion), T-Mobile US, Inc. ($3.94 billion), Charter Communications, Inc. ($3.77 billion), Occidental Petroleum Co. ($3.27 billion), Tractor Supply ($2.29 billion), Celsius Holdings, Inc. ($2.20 billion), Rivian Automotive, Inc. ($2.10 billion), Moderna, Inc. ($2.08 billion), Royal Caribbean Cruises Ltd. ($1.90 billion), and T. Rowe Price Group, Inc. ($1.90 billion). View all of the most shorted stocks.

Short selling LMNL is an investing strategy that aims to generate trading profit from Liminal BioSciences as its price is falling. LMNL shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Liminal BioSciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of LMNL, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LMNL, twice per month. The most recent reporting period available is September, 15 2023.